This announcement is a separate document:
アステラス製薬：IZERVAY（avacincaptad pegol） 米国における一部変更承認申請に関する最新情報
Astellas Pharma: The latest information on IZERVAY (avacincaptad pegol) partial change approval application in the US
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated